What are the Historical Developments and Current Growth Metrics of the Type 2 Diabetes Market?
The type 2 diabetes market has seen considerable growth due to a variety of factors.
• Over the past few years, there has been a substantial growth in the market size of type 2 diabetes. The estimate projects a rise from $48.14 billion in 2024 to $51.96 billion in 2025, which indicates a compound annual growth rate (CAGR) of 7.9%.
Factors such as changes in lifestyle and diet, aging population, advancements in pharmaceuticals, and public health initiatives fuelled the growth during the historic period.
What is the Forecasted Market Size and CAGR for the Type 2 Diabetes Market?
The type 2 diabetes market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for type 2 diabetes is predicted to experience robust expansion over the upcoming years. It is set to reach $72.22 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.6%.
The growth during the forecast period is due to factors such as the worldwide diabetes epidemic, personal medication advancements, evolution in technology, and modifications in healthcare policies. Noteworthy trends during this forecast period consist of digital health and telemedicine, proactive prevention and early intervention measures, the usage of artificial intelligence (AI) and machine learning (ML), and metabolic surgery.
What Key Factors and Trends Are Driving The Growth Type 2 Diabetes Market?
The projection of the type 2 diabetes market is set to expand, primarily driven by the escalating rates of obesity and heart disease. Obesity, a health condition marked by excessive body fat levels, and heart disease, a term encompassing a variety of heart and blood vessels-related conditions, are becoming prevalent. Overweight individuals are at higher risk of insulin resistance, which can cause elevated blood sugar levels, thus triggering the development of type 2 diabetes. Conversely, high blood sugar levels can inflict damage upon blood vessels and nerves controlling the heart and blood vessels, leading to heart ailments. For instance, in March 2024, the World Health Organization (WHO), a Swiss-based intergovernmental entity, revealed that about one-eighth of the global population were grappling with obesity. This comprised 2.5 billion overweight adults who are 18 years and above, with 890 million of them suffering from obesity. Among these adults, 43% were overweight, and 16% were categorized as obese. Moreover, the count of overweight children aged under 5 hit 37 million. Hence, the rising incidences of obesity and heart disease are stimulating the growth of the type 2 diabetes market.
Type 2 Diabetes Market Driver: Surge in Elderly Population Fuels Type 2 Diabetes Market Expansion
What Are The Market Segments In The Type 2 Diabetes Market?
The type 2 diabetes market covered in this report is segmented –
1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes
2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications
3) By End-User: Children, Adults
Subsegments:
1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide
3) By Thiazolidinediones: Pioglitazone, Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide
6) By Biguanides: Metformin
7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin
8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists
Pre-Book The Type 2 Diabetes Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Type 2 Diabetes Market?
Leading firms immersed in the type 2 diabetes industry are innovating with new products like Mounjaro, aiming to elevate safety and efficacy for patients with diabetes. The objective of these trailblazing medications such as Mounjaro is to improve the effectiveness, safety, and manageability of diabetes treatment compared to traditional drugs. The creative evolution in diabetes medication formulation concentrates on enhancing blood glucose management, reducing potential side effects, and tackling other related health issues. To illustrate, in May 2022, the U.S. Food and Drug Administration granted approval to Eli Lilly and Co., a pharmaceutical organization based in the U.S., for their Mounjaro (tripeptide) injection designed to upgrade blood glucose control in adults with type 2 diabetes, in tandem with diet and physical exercise. Tirzepatide positions itself as a fresh, dual-action treatment for type 2 diabetes. Administered weekly through an injection, it impacts two hormones responsible for the regulation of blood sugar levels, namely glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). While GLP-1 amplifies insulin production and reduces glucagon production, GIP enhances insulin production. Therefore, Tirzepatide stands as a hopeful new treatment pathway for individuals with type 2 diabetes, even those who have failed to see benefits from previous treatments.
Who Are the Key Players In The Type 2 Diabetes Market?
Major companies operating in the type 2 diabetes market are:
• F. Hoffmann-La Roche AG
• Merck and Co. Inc.
• Novartis AG
• AstraZeneca PLC
• Abbott Laboratories
• Sanofi SA
• Medtronic PLC
• Takeda Pharmaceutical Company
• GlaxoSmithKline plc.
• Eli Lilly and Company
• Novo Nordisk A/S
• Johnson And Johnson Private Limited
• Daiichi Sankyo Co. Ltd.
• Boehringer Ingelheim International GmbH
• Dexcom Inc.
• Amgen Inc.
• Insulet Corporation
• Ascensia Diabetes Care
• Byram Healthcare
• Beta Bionics
• Onduo LLC
• DarioHealth
• One Drop
• Bigfoot Biomedical Inc.
• Digbi Health
• MySugr GmbH
• Senseonics Holdings Inc.
• Provention Bio Inc.
• Vida Health Inc.
• Diathrive Health.
What Are The Regional Insights Into The Type 2 Diabetes Market?
North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
